CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
106 hedge funds and large institutions have $186M invested in Cymabay Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $213M → $186M (-$27.1M)
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
Holders
106
Holding in Top 10
6
Calls
$801K
Puts
$345K
Top Buyers
| 1 | +$4.65M | |
| 2 | +$3.54M | |
| 3 | +$2.21M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.11M |
| 5 |
Millennium Management
New York
|
+$1.9M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$3.89M | |
| 3 | -$2.95M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.94M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.78M |